The impact of vorinostat and AGS-004, a dendritic cell-based immunotherapy, on persistent HIV-1 Infection - C. Gay; J.D. Kuruc; S.D. Falcinelli; J. Warren; J.L. Kirchherr; K. Sholtis; B. Allard; E. Stuelke; A. Gamble; A. Plachco; I. Tcherapanova; J.J. Eron; et al. (Elsevier, 2019)